CJC-1295 – With DAC 2mg × 10 vials
provides advanced peptide support commonly associated with recovery, restorative balance, and body composition-focused wellness routines. Featuring ten 2mg vials, this research-focused peptide is frequently discussed in connection with growth hormone pathway research, performance, vitality, and healthy aging. For research and educational purposes only.
65$
Description
CJC-1295 With DAC 2mg × 10 vials
A long-acting synthetic growth hormone-releasing hormone analogue studied for growth hormone signaling, IGF-1 response, pituitary activity, endocrine research, recovery pathways, and body composition support protocols.
Product Overview
Compound: CJC-1295 With DAC
Strength: 2 mg per vial
Injection type: Subcutaneous
Frequency: Research protocol dependent
Reconstitution
Amount in vial: 2 mg
BAC water: 2 mL
Amount per unit: 10 mcg per unit
Research Dose
Protocol dependent.
Notes
CJC-1295 With DAC is a modified GHRH analogue containing a Drug Affinity Complex. The DAC modification allows the compound to bind to endogenous albumin, extending its half-life compared with shorter-acting GHRH analogues.
It has been studied for sustained growth hormone and IGF-1 response, pituitary signaling, endocrine research, recovery-related pathways, and body composition protocols.
No standard consumer dosing protocol should be assumed. Use only within appropriate research or professional guidance frameworks.
Disclaimer
This product is intended for research and informational purposes only.
Additional information
| Weight | 65 g |
|---|
Reviews
There are no reviews yet.